SCHEMBL467753

SCHEMBL467753

CCOC[SiH](OCC)OCC

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27779418 0.76 TSHR (0.41) ALDH1A1
SCHEMBL467584 0.75
SCHEMBL467776 0.75
SCHEMBL319955 0.71
SCHEMBL5862095 0.71 ALDH1A1 (0.39) ALDH1A1
SCHEMBL707438 0.69
SCHEMBL704930 0.69
SCHEMBL2239332 0.69 ALDH1A1 (0.35) ALDH1A1
SCHEMBL329934 0.69
SCHEMBL18614587 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4703405-A1 CRYSTALLINE POLYOXYALKYLENE-BASED POLYMER AND CURABLE COMPOSITION COMPRISING SAME Kaneka Corporation (JP) 2026-03-04 EP disclosed
EP-3950832-B1 CURABLE COMPOSITION AND CURED PRODUCT KANEKA CORP (JP) 2025-10-22 EP disclosed
EP-3889206-B1 POLYOXYALKYLENE POLYMER AND CURABLE COMPOSITION KANEKA CORP (JP) 2025-10-15 EP disclosed
EP-4596622-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2025-08-06 EP disclosed
US-12378406-B2 Mixture of polyoxyalkylene polymers and curable composition KANEKA CORPORATION (JP) 2025-08-05 US disclosed
EP-4105262-B1 CURABLE COMPOSITION AND CURED PRODUCT THEREOF KANEKA CORP (JP) 2025-04-02 EP disclosed
US-12234322-B2 Polyoxyalkylene polymer and curable composition KANEKA CORPORATION (JP) 2025-02-25 US disclosed
US-12152143-B2 Curable composition and cured product KANEKA CORPORATION (JP) 2024-11-26 US disclosed
CN-115335455-B Mixture of polyoxyalkylene polymer and curable composition 株式会社钟化 2024-11-19 CN disclosed
WO-2024224831-A1 CRYSTALLINE POLYOXYALKYLENE-BASED POLYMER AND CURABLE COMPOSITION COMPRISING SAME 株式会社カネカ 2024-10-31 WO disclosed
US-20130217828-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2013-08-22 US disclosed
EP-2604655-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2013-06-19 EP disclosed
US-20120196981-A1 METHOD FOR PRODUCING a-HETERO-SUBSTITUTED ALKYLHALOHYDROSILANE AND USE THEREOF KANEKACORPORATION (JP) 2012-08-02 US disclosed
EP-2392600-A1 Polymer having a reactive silicon-containing group, methods for its preparation and a curable composition comprising the polymer Kaneka Corporation (JP) 2011-12-07 EP disclosed
EP-2386561-A1 Methods for producing alkoxyhydrosilanes Kaneka Corporation (JP) 2011-11-16 EP disclosed
US-8039142-B2 Battery case SONY CORPORATION (JP) 2011-10-18 US disclosed
US-20110207886-A1 Method for Producing a-hereto-Substituted Alkylhalohydrosilane and Use Thereof KANEKA CORPORATION (JP) 2011-08-25 US disclosed
EP-2308884-A1 METHOD FOR PRODUCING -HETERO-SUBSTITUTED ALKYLHALOHYDROSILANE AND USE THEREOF Kaneka Corporation (JP) 2011-04-13 EP disclosed
US-20090247712-A1 CURABLE ORGANIC POLYMER AND METHOD FOR PRODUCTION THEREOF, AND CURABLE COMPOSITION CONTAINING THE SAME KANEKA CORPORATION (JP) 2009-10-01 US disclosed
EP-2080777-A1 HARDENING ORGANIC POLYMER, PROCESS FOR PRODUCING THE SAME, AND HARDENING COMPOSITION CONTAINING THE POLYMER Kaneka Corporation (JP) 2009-07-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196981-A1 METHOD FOR PRODUCING a-HETERO-SUBSTITUTED ALKYLHALOHYDROSILANE AND USE THEREOF ARSA, HACL2, AS3MT ALDH1A1 2288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.